Jeff McKinney, NP, and Glen Lutchman, MD, are successfully curing Hepatitis C using new direct acting antiviral agents that prevent the virus from replicating. The two treat all hepatology patients at Stanford, including those with mild disease, patients on the transplant list and patients post-transplant.

This is a massive leap from a year of treatment that offered a 40 percent cure rate, and a 24 week treatment regimen that only bumped that cure rate to 60 percent.

-Glen Lutchman, MD